Clinical trial results have demonstrated that the Pfizer-BioNTech Covid-19 vaccine is safe to be used in children aged five to 11 years. — AFP
Brown University School of Public Health dean and a leading Covid expert in the US Dr Ashish Jha called it the “good news” many parents had been waiting for.The trial results are the first of their kind for children under 12, with a Moderna trial for six- to 11-year-olds still ongoing. Kids in the five to 11 years age group received a two-dose regimen of 10mcg in the trial, compared with 30mcg for older age groups, the companies said.The 10mcg dose was “carefully selected as the preferred dose for safety, tolerability and immunogenicity” for that age group, the statement said.
The statement made no mention of the rare side effect of myocarditis – an inflammation of the heart muscle that has been linked to the vaccine, mostly among younger males. Pfizer and BioNTech are also trialling their vaccine on infants aged six months to two years, and on children aged two to five.
Malaysia Latest News, Malaysia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.